Cerity Partners’s Synovus SNV Stock Holding History

Cerity Partners’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-99,387	Closed	-$4.97M	–	3386
2025 Q4	$4.97M	Buy	99,387 +28,893	+41%	+$1.39M	0.01%	926
2025 Q3	$3.46M	Buy	70,494 +56,721	+412%	+$2.91M	0.01%	1033
2025 Q2	$713K	Sell	13,773 -10,106	-42%	-$464K	﹤0.01%	1689
2025 Q1	$1.12M	Buy	23,879 +8,059	+51%	+$416K	﹤0.01%	1380
2024 Q4	$767K	Buy	15,820 +1,092	+7%	+$56.6K	﹤0.01%	1539
2024 Q3	$655K	Buy	14,728 +8,549	+138%	+$374K	﹤0.01%	1626
2024 Q2	$248K	Sell	6,179 -2,498	-29%	-$94.7K	﹤0.01%	1917
2024 Q1	$348K	Buy	+8,677	New	+$326K	﹤0.01%	1781

Other funds holding SNV

WBWA

William B. Walkup & Associates Columbia, South Carolina $167M AUM 20.75% 1-Year Est. Return

Cerity Partners's SNV Position: Q1 2026 in Review

Cerity Partners sold out of Synovus (SNV) in Q1 2026, closing a stake of 99,387 shares — an estimated $4.97M sold.

Cerity Partners first reported a position in SNV in Q1 2024 and held it in 8 quarters. The position peaked at $4.97M in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

Cerity Partners reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
Cerity Partners sold 99,387 Synovus shares in Q1 2026, an estimated $4.97M.
Cerity Partners first reported a position in Synovus in Q1 2024 and held it in 8 quarters.
Cerity Partners's Synovus position peaked at $4.97M in Q4 2025.
1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.